164 related articles for article (PubMed ID: 14716239)
21. Teaching NeuroImages: MRI in maple syrup urine disease.
Bindu PS; Kovoor JM; Christopher R
Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
[No Abstract] [Full Text] [Related]
22. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
[No Abstract] [Full Text] [Related]
23. [Early assessment of severe hypoxic-ischemic encephalopathy in neonates by diffusion-weighted magnetic resonance imaging techniques and its significance].
Fu JH; Xue XD; Mao J; Chen LY; Wang XM
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):843-7. PubMed ID: 18282417
[TBL] [Abstract][Full Text] [Related]
24. CT and MRI in maple syrup urine disease.
Uziel G; Savoiardo M; Nardocci N
Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
[TBL] [Abstract][Full Text] [Related]
25. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience.
Guo AC; Petrella JR; Kurtzberg J; Provenzale JM
Radiology; 2001 Mar; 218(3):809-15. PubMed ID: 11230660
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
Xia W; Yang W
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
[No Abstract] [Full Text] [Related]
29. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
[TBL] [Abstract][Full Text] [Related]
30. [Neonatal presentation of maple syrup urine disease].
Cardoen L; Schiff M; Lambron J; Rega A; Virlouvet AL; Biran V; Eleni Dit Trolli S; Elmaleh-Bergès M; Alison M
Arch Pediatr; 2016 Dec; 23(12):1291-1294. PubMed ID: 27816400
[No Abstract] [Full Text] [Related]
31. MRI findings of adult maple syrup urine disease exacerbation.
Rawal S; Faghfoury H; Krings T
Can J Neurol Sci; 2013 Mar; 40(2):259-62. PubMed ID: 23419580
[No Abstract] [Full Text] [Related]
32. Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system.
Jain A; Jagdeesh K; Mane R; Singla S
J Clin Neonatol; 2013 Apr; 2(2):98-100. PubMed ID: 24049754
[TBL] [Abstract][Full Text] [Related]
33. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
[TBL] [Abstract][Full Text] [Related]
34. [Maple syrup urine disease].
Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
[No Abstract] [Full Text] [Related]
35. Imaging in neonatal maple syrup urine disease.
Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S
Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353
[No Abstract] [Full Text] [Related]
36. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
[TBL] [Abstract][Full Text] [Related]
37. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging.
Neil JJ; Shiran SI; McKinstry RC; Schefft GL; Snyder AZ; Almli CR; Akbudak E; Aronovitz JA; Miller JP; Lee BC; Conturo TE
Radiology; 1998 Oct; 209(1):57-66. PubMed ID: 9769812
[TBL] [Abstract][Full Text] [Related]
38. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
[TBL] [Abstract][Full Text] [Related]
39. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
[TBL] [Abstract][Full Text] [Related]
40. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
